Erica Lubetkin to Cross-Sectional Studies
This is a "connection" page, showing publications Erica Lubetkin has written about Cross-Sectional Studies.
Connection Strength
0.370
-
Lubetkin EI, Guidry JA, Webb A, Ocampo A, Burkhalter JE. Examining transdiagnostic vulnerabilities among HIV positive smokers seen at three inner city community based organizations. AIDS Care. 2018 Feb; 30(2):140-145.
Score: 0.075
-
Lubetkin EI, Lu WH, Gold MR. Levels and correlates of patient activation in health center settings: building strategies for improving health outcomes. J Health Care Poor Underserved. 2010 Aug; 21(3):796-808.
Score: 0.046
-
Johnson JA, Janssen MF, Al Sayah F, Bailey H, Gandhi M, Golicki D, Gutacker N, Lubetkin E, Mulhern B, Purba FD, Ramos-Go?i JM, Scott D, Short H, Sullivan T, Viney R, Yang Z, Z?rate V. EuroQol data for assessment of population health needs and instrument evaluation (EQ-DAPHNIE): a study for enhancing population health assessment. Qual Life Res. 2025 Dec; 34(12):3321-3334.
Score: 0.032
-
Scott ES, Lubetkin EI, Janssen MF, Yfantopolous JN, Bonsel GJ, Haagsma JA. The performance relationship between the EQ-5D-5L composite "Anxiety/Depression" dimension and anxiety and depression symptoms in a large, general population sample. Qual Life Res. 2024 Nov; 33(11):3107-3119.
Score: 0.031
-
Lee P, Engel L, Lubetkin E, Gao L. Exploring the Comparability Between EQ-5D and the EQ Health and Wellbeing in the General Australian Population. Value Health. 2024 04; 27(4):508-517.
Score: 0.029
-
Lubetkin EI, Gold MR. Areas of decrement in health-related quality of life (HRQL): comparing the SF-12, EQ-5D, and HUI 3. Qual Life Res. 2003 Dec; 12(8):1059-67.
Score: 0.029
-
Lee P, Bowe SJ, Engel L, Lubetkin EI, Devlin N, Gao L. An Intersectional Approach to Quantifying the Impact of Geographic Remoteness and Health Disparities on Quality-Adjusted Life Expectancy: Application to Australia. Value Health. 2023 12; 26(12):1763-1771.
Score: 0.029
-
Lubetkin EI, Jia H, Gold MR. Depression, anxiety, and associated health status in low-income Chinese patients. Am J Prev Med. 2003 May; 24(4):354-60.
Score: 0.028
-
Lubetkin EI, Jia H, Gold MR. Use of the SF-36 in low-income Chinese American primary care patients. Med Care. 2003 Apr; 41(4):447-57.
Score: 0.028
-
Lubetkin EI, Gold MR. Comprehensibility of measures of health-related quality of life in minority and low-income patients. J Natl Med Assoc. 2002 May; 94(5):327-35.
Score: 0.026
-
Hung DY, Lubetkin EI, Fahs MC, Shelley DR. Assessing the impact of behavioral risk factors and known-groups validity of the SF-12 in a US Chinese immigrant population. Med Care. 2009 Feb; 47(2):262-7.
Score: 0.010
-
Franks P, Lubetkin EI, Gold MR, Tancredi DJ. Mapping the SF-12 to preference-based instruments: convergent validity in a low-income, minority population. Med Care. 2003 Nov; 41(11):1277-83.
Score: 0.007